MedPath
HSA Approval

DIOX POWDER FOR INJECTION 10 mg/vial

SIN12500P

DIOX POWDER FOR INJECTION 10 mg/vial

DIOX POWDER FOR INJECTION 10 mg/vial

January 10, 2004

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

L01DB01

doxorubicin

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

DAE HAN NEW PHARM. CO. LTD.

Active Ingredients

DOXORUBICIN HCl

10 mg/vial

Doxorubicin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIOX POWDER FOR INJECTION 10 mg/vial - HSA Approval | MedPath